Integrated Biosciences uses synthetic biology and machine learning to develop therapeutics for age-related diseases.

Actym Therapeutics develops a new drug modality using genetically modified bacteria to initiate a selective immune response within the tumor microenvironment for treating solid tumors.

Broken String Biosciences is a genomics company that develops safer cell and gene therapies by using its INDUCE-seq DNA break mapping technology to measure off-target effects in clinically relevant cells, aiming to enhance the efficiency, safety, and affordability of cell and gene therapies.